PHK
CRNX icon

Point72 Hong Kong’s Crinetics Pharmaceuticals CRNX Stock Holding History

Point72 Hong Kong’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,790
Closed -$224K – 488
2025
Q2 		$224K Buy
+7,790
New +$241K 0.01% 295
2021
Q4 		– Sell
-2,438
Closed -$51K – 1976
2021
Q3 		$51K Buy
+2,438
New +$51K ﹤0.01% 1517
2021
Q1 		– Sell
-28
Closed – – 1861
2020
Q4 		$0 Buy
28
+20
+250% +$279 ﹤0.01% 1775
2020
Q3 		$0 Buy
+8
New +$122 ﹤0.01% 1245

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Point72 Hong Kong's CRNX Position: Q3 2025 in Review

Point72 Hong Kong sold out of Crinetics Pharmaceuticals (CRNX) in Q3 2025, closing a stake of 7,790 shares — an estimated $224K sold.

Point72 Hong Kong first reported a position in CRNX in Q3 2020 and held it in 4 quarters. The position peaked at $224K in Q2 2025. 225 funds tracked by Wall St. Rank hold CRNX as of Q3 2025.

  • Point72 Hong Kong reported no remaining Crinetics Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 7,790 Crinetics Pharmaceuticals shares in Q3 2025, an estimated $224K.
  • Point72 Hong Kong first reported a position in Crinetics Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Crinetics Pharmaceuticals position peaked at $224K in Q2 2025.
  • 225 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.